Literature DB >> 12359426

Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain.

Raleigh D Kladney1, Ann E Tollefson, William S M Wold, Claus J Fimmel.   

Abstract

GP73 is a novel type II Golgi transmembrane protein that is expressed at high levels in the hepatocytes of patients with viral hepatitis (R. D. Kladney, G. A. Bulla, L. Guo, A. L. Mason, A. E. Tollefson, D. J. Simon, Z. Koutoubi, and C. J. Fimmel, 2000, Gene 249, 53-65) and is induced in cultured cells by infection with viruses including adenoviruses. Its biological function and the mechanisms by which its expression may be regulated by viral infection are unknown. Here we report that GP73 is induced at the RNA and protein level in human Hep3B hepatoma cells infected by human Ad5 and Ad2. Hep3B cells were infected with wild-type or mutant adenoviruses. GP73 expression was measured by RNase protection assay, immunoblotting, or immunofluorescence microscopy. GP73 RNA and protein levels were strikingly induced following infection. The rise in GP73 expression coincided with the appearance of the adenovirus E1A and DBP proteins and preceded the expression of the fiber protein, a marker of the late phase of infection. Infection did not affect the expression of giantin, GPP130, or golgin-84, three integral Golgi membrane proteins with structural similarities to GP73. Mapping studies using a panel of mutant adenoviruses demonstrated that the E1A C-terminus, specifically its CtBP interaction domain (CID), is required for GP73 expression. Subsequently, Hep3B cells were transiently transfected with plasmids expressing wild-type or mutant E1A proteins. These studies confirmed that E1A induced GP73 expression via the CID. Our studies establish GP73 as a novel adenovirus-induced cellular protein whose expression is regulated through the CID of the E1A protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359426     DOI: 10.1006/viro.2002.1523

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.

Authors:  Hongyan Liang; Timothy M Block; Mengjun Wang; Bradley Nefsky; Ronald Long; Julie Hafner; Anand S Mehta; Jorge Marrero; Robert Gish; Pamela A Norton
Journal:  Cancer Biomark       Date:  2012       Impact factor: 4.388

2.  Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.

Authors:  Sooryanarayana Varambally; Bharathi Laxman; Rohit Mehra; Qi Cao; Saravana M Dhanasekaran; Scott A Tomlins; Jill Granger; Adaikkalam Vellaichamy; Arun Sreekumar; Jianjun Yu; Wenjuan Gu; Ronglai Shen; Debashis Ghosh; Lorinda M Wright; Raleigh D Kladney; Rainer Kuefer; Mark A Rubin; Claus J Fimmel; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

3.  GOLPH2 expression may serve as diagnostic marker in seminomas.

Authors:  Florian R Fritzsche; Glen Kristiansen; Marc-Oliver Riener; Manfred Dietel; Beibei Oelrich
Journal:  BMC Urol       Date:  2010-02-25       Impact factor: 2.264

4.  Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Effect of GP73 silencing on proliferation and apoptosis in hepatocellular cancer.

Authors:  Yu-Long Zhang; You-Cheng Zhang; Wei Han; Yu-Min Li; Geng-Nian Wang; Shao Yuan; Feng-Xian Wei; Jia-Feng Wang; Jian-Jun Jiang; Ya-Wu Zhang
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.

Authors:  Jin-song Hu; De-wu Wu; Shuo Liang; Xiong-yin Miao
Journal:  Med Oncol       Date:  2009-04-28       Impact factor: 3.064

Review 7.  GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.

Authors:  Ming-Chen Ba; Hui Long; Yun-Qiang Tang; Shu-Zhong Cui
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

8.  GOLM1 restricts colitis and colon tumorigenesis by ensuring Notch signaling equilibrium in intestinal homeostasis.

Authors:  Yang Pu; Ya Song; Mengdi Zhang; Caifeng Long; Jie Li; Yanan Wang; Yinzhe Xu; Fei Pan; Na Zhao; Xinyu Zhang; Yanan Xu; Jianxin Cui; Hongying Wang; Yan Li; Yong Zhao; Di Jin; Hongbing Zhang
Journal:  Signal Transduct Target Ther       Date:  2021-04-14

9.  Golgi phosphoprotein 2 in physiology and in diseases.

Authors:  Ha-Jeong Kim; Dandan Lv; Yan Zhang; Tao Peng; Xiaojing Ma
Journal:  Cell Biosci       Date:  2012-09-10       Impact factor: 7.133

10.  GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics.

Authors:  G Kristiansen; F R Fritzsche; K Wassermann; C Jäger; A Tölls; M Lein; C Stephan; K Jung; C Pilarsky; M Dietel; H Moch
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.